DUBLIN, February 04, 2022–(BUSINESS WIRE)–The report “Inhalable Drug Delivery Devices – Medical Devices Pipeline Product Landscape, 2021” has been added to from ResearchAndMarkets.com offer.

This report provides comprehensive information about the products in the Inhalable Drug Delivery Devices pipeline with a comparative analysis of products at different stages of development and information about ongoing clinical trials.

The inhalable drug delivery device is intended to deliver drugs that need to be inhaled deep into the lungs.


  • Extensive coverage of inhalable drug delivery devices under development

  • The report examines details of major pipeline products including product description, licensing and collaboration details and other development activities.

  • The report reviews key players involved in the development of Inhalable Drug Delivery Devices and lists all their pipeline projects

  • Pipeline product coverage based on various stages of development ranging from early development stage to approved/released stage

  • The report provides key clinical trial data from ongoing trials specific to pipeline products

  • Recent developments in the segment/industry

Reasons to buy

The report allows you to:

  • Formulate important competitor information, analysis and insights to improve R&D strategies

  • Identify emerging players with a potentially strong product pipeline and create effective counter-strategies to gain competitive advantage

  • Identify and understand the important and diverse types of inhalable drug delivery devices under development

  • Develop market entry and expansion strategies

  • Effectively plan mergers and acquisitions by identifying key players with the most promising pipeline

  • In-depth analysis of current product development stage, territory and estimated launch date

Main topics covered:

1 Table of Contents

2 Presentation

3 products in development

3.1 Inhalable Drug Delivery Devices – Pipeline Products by Development Stage

3.2 Inhalable Drug Delivery Devices – Pipeline Products by Segment

3.3 Inhalable Drug Delivery Devices – Pipeline Products by Territory

3.4 Inhalable Drug Delivery Devices – Pipeline Products by Regulatory Route

3.5 Inhalable Drug Delivery Devices – Pipeline Products by Estimated Approval Date

3.6 Inhalable Drug Delivery Devices – Ongoing Clinical Trials

4 Inhalable Drug Delivery Devices – Pipeline Products Under Development by Companies

4.1 Inhalable Drug Delivery Company-Pipeline Products by Development Stage

4.2 Inhalable Drug Delivery Devices – Pipeline Products by Development Stage

5 Inhalable Medicine Delivery Companies and Product Overview

6 Administration of Inhalable Medications – Recent Developments

7 Appendix

Companies cited

  • Acorda Therapeutics Inc

  • Actervis GmbH

  • Aerami Therapeutics Inc

  • Aerophase Inc

  • Alexza Pharma Inc.

  • Atossa Therapeutic Inc

  • Baxter International Inc.

  • Bellerophon Therapeutics Inc

  • Breath Therapeutics Holding BV

  • California Northstate University College of Medicine

  • Canigma AL LTD

  • Edixomed Ltd

  • Engage Therapeutics Inc

  • iDTx Systems, Inc.

  • Impel NeuroPharma Inc

  • Inhalation Sciences Sweden AB

  • InhaleRx Ltd

  • Invero Pharma LLC

  • Jupiter Research LLC

  • Kanabo Research Ltd.

  • Mallinckrodt Plc

  • Medical Developments International Ltd

  • Medspray B.V.

  • Monash University

  • Nemera La Verpilliere

  • NextSafety, Inc.

  • Nobilis Therapeutics Inc

  • OncoSec Medical Inc

  • Parnell Pharmaceuticals Inc.

  • Pharmosa Biopharm Inc.

  • Rhinomed Limited

  • Rutgers Cancer Institute of New Jersey

  • Sandoz International GmbH

  • Seng Vital International GmbH

  • Shenzhen Smoore Technology Ltd.

  • Technology Marketing Partners LLC

  • Tetra Bio-Pharma Inc.

  • Teva Pharmaceutical Industries Ltd

  • Texas Tech University Health Sciences Center

  • Third Pole Inc.

  • Tiziana Life Sciences PLC

  • Torrent Pharmaceuticals Ltd

  • Southampton University Hospital NHS Foundation Trust

  • University of Texas Health Sciences Center at Houston

  • Vectura Plc Group

  • Veoli SA

  • Vero Biotech LLC

  • Via Therapeutics LLC

  • Virpax Pharmaceuticals Inc

  • VistaGen Therapeutics Inc

  • VitalMIST

  • Windtree Therapeutics Inc

For more information about this report visit https://www.researchandmarkets.com/r/ryyqk1

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220204005433/en/


Laura Wood, Senior Press Officer
[email protected]

For EST business hours, call 1-917-300-0470
For US/CAN call toll free 1-800-526-8630
For GMT office hours call +353-1-416-8900